CD79A and COVID-19: Observations that nasal IgA antibody levels correlate with SARS-CoV-2 neutralization in vitro and with less severe COVID-19 [36,38], and that neutralizing IgA antibodies in the URT are detectable at least 73d after infection [39], additionally illustrate the importance of adaptive immunity in the URT for protection against infection.